Transaction · 0000914475-25-000071

SHERWIN STEPHEN A

SHERWIN STEPHEN A, DIR, reported an open-market or private sale at NEUROCRINE BIOSCIENCES INC involving 13831.000000 shares for an estimated $1613922.79. Reported holdings after the transaction were 10673.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
NBIXNEUROCRINE BIOSCIENCES INC
Filing timeFeb 14
Trade dateFeb 13, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

NBIX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NBIX since 2025-02-14Filed 567 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000914475-25-000071
Common Stock
Transaction date
Feb 13, 2025
Filed Feb 14, 2025, 11:49 PM · 1d delay
Shares
13.8k sh
$11.6k per share
Estimated value
-$161M
Computed from shares × price
Holdings after
10.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Holdings Reduction Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024. Additionally, Iss…

  2. F2

    Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.79 to $118.33. The Reporting Person has provided to the issuer, and wil…

Original filing · 0000914475-25-000071
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NBIX